Geetha Ajay
School · South Ozone Park, NYNPI 1235404443
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Boston Scientific at 46.5% of the total. Reporting peaked in 2023 at $563 and has fallen 92.9% since, to $40 in 2025.
Across 33 payments — averaging $25.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$386
- Kowa Pharmaceuticals America, Inc.$194
- Azurity Pharmaceuticals, Inc.$65
- Amgen$63
- Collegium Pharmaceutical, Inc.$36
- Pfizer$29
- plus $57 from 3 others
What the payments were for
- Food & beverage$830100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 5 | $386 |
| Kowa Pharmaceuticals America, Inc. | 13 | $194 |
| Azurity Pharmaceuticals, Inc. | 4 | $65 |
| Amgen | 4 | $63 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| Pfizer | 2 | $29 |
| Medtronic | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Metacel Pharmaceuticals LLC | 1 | $17 |
How this compares
$830 in reported general payments places this provider in the 85th percentile of 23 school providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZtlidoLidocaine | 129 | $48,180 |
| Diclofenac Sodium | 165 | $18,259 |
| HorizantGabapentin Enacarbil | 17 | $8,122 |
| Lidocaine | 118 | $7,579 |
| Gabapentin | 786 | $6,830 |
| Pregabalin | 324 | $5,681 |
| OxycontinOxycodone Hcl | 12 | $4,948 |
| MovantikNaloxegol Oxalate | 11 | $4,091 |
| Tizanidine Hcl | 313 | $2,376 |
| Naproxen | 122 | $2,250 |
| Diclofenac Sodium ErDiclofenac Sodium | 25 | $1,926 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 239 | $1,744 |
| Cyclobenzaprine Hcl | 283 | $1,635 |
| Duloxetine Hcl | 128 | $1,620 |
| Methadone Hcl | 95 | $1,594 |
Paid to pharmacies, not to this prescriber.
Other school in South Ozone Park
- Maria SpinosoBaldwin$4K
- Susan ButlerBuffalo$1K
- Sandra BaffourBrooklyn$889
- Sarah GoldbergNew York$335
- Ellen JohnsonHopewell Junction$172
- Bethany MooreWilliamson$75
- Abiola DaramolaBronx$74
- Jodi-Kaye McGhieWhite Plains$73
- Colleen AmidonHornell$72
- Ann SangerHilton$52
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.